Valuation: Cencora, Inc.

Market Cap 57.98B 50.99B 48.22B 43.73B 82.13B 5,565B 82.61B 577B 223B 2,840B 218B 213B 9,125B P/E 2026 *
16.6x
P/E 2027 * 18.2x
Enterprise Value 65.67B 57.75B 54.61B 49.53B 93.03B 6,303B 93.57B 654B 253B 3,216B 247B 241B 10,336B EV / Sales 2026 *
0.19x
EV / Sales 2027 * 0.19x
Free-Float
61.21%
Yield 2026 *
0.78%
Yield 2027 * 0.8%
1 day-1.84%
1 week-0.04%
Current month-2.98%
1 month-4.20%
3 months+6.93%
6 months-2.32%
Current year-15.17%
1 week 266.8
Extreme 266.8
273.1
1 month 266.5
Extreme 266.5
287.1
Current year 212.9
Extreme 212.9
316.5
1 year 212.9
Extreme 212.9
327.1
3 years 171.2
Extreme 171.2
327.1
5 years 101
Extreme 101
327.1
10 years 58.64
Extreme 58.644
327.1
Manager TitleAgeSince
Chief Executive Officer 59 2024-09-30
Director of Finance/CFO 59 2026-06-28
Chief Tech/Sci/R&D Officer 50 2024-11-03
Director TitleAgeSince
Director/Board Member 75 2013-05-15
Director/Board Member 59 2024-09-30
Chairman 64 2025-09-30
Change 5-day change 1-year change 3-year change Capi.($)
-1.84%-0.04% - - 58.57B
-0.31%-1.59%-24.39%+5.71% 175B
+0.97%-2.85%-5.01%+14.42% 113B
-1.01%-1.61%-1.04%+64.08% 58.57B
+0.01%+1.60%-0.42%-28.97% 50.07B
-0.40%+1.06%+15.03%+54.05% 49.92B
+0.07%-2.99%+29.18%-5.87% 32.69B
+1.07%+10.84% - - 30.44B
+1.41%+3.68%+43.64%+0.13% 26.07B
+1.98%+7.44%+26.26%-1.90% 23.55B
Average +0.20%+1.51%+10.41%+12.70% 62.22B
Weighted average by Cap. -0.01%-0.09%-2.76%+13.98%

Financials

2026 *2027 *
Net sales 337B 296B 280B 254B 477B 32,350B 480B 3,356B 1,296B 16,508B 1,265B 1,238B 53,047B 353B 310B 294B 266B 500B 33,882B 503B 3,515B 1,357B 17,289B 1,325B 1,296B 55,559B
Net income 3.58B 3.15B 2.98B 2.7B 5.07B 344B 5.1B 35.65B 13.77B 175B 13.44B 13.15B 564B 2.84B 2.5B 2.37B 2.15B 4.03B 273B 4.05B 28.33B 10.94B 139B 10.68B 10.45B 448B
Net Debt 7.69B 6.76B 6.4B 5.8B 10.89B 738B 10.96B 76.58B 29.58B 377B 28.87B 28.25B 1,211B 9.44B 8.3B 7.85B 7.12B 13.37B 906B 13.45B 93.97B 36.29B 462B 35.43B 34.66B 1,485B
Logo Cencora, Inc.
Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).
Employees
49,000
Date Price Change
26-09-28 €266.80 -1.84%
26-09-25 €271.80 +0.07%
26-09-24 €271.60 -0.29%
26-09-23 €272.40 -0.26%
26-09-22 €273.10 +2.48%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
303.81USD
Average target price
369.25USD
Spread / Average Target
+21.54%

Quarterly revenue - Rate of surprise